about
Prevalence of attention deficit hyperactivity disorder among children and adolescents in Spain: a systematic review and meta-analysis of epidemiological studiesFunctional consequences of attention-deficit hyperactivity disorder on children and their families.Italian regional health service costs for diagnosis and 1-year treatment of ADHD in children and adolescents.Influence of a latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD).A population-based study of attention deficit/hyperactivity disorder symptoms and associated impairment in middle-aged adults.Occupational issues of adults with ADHD.Moment-to-moment dynamics of ADHD behaviour in South African children.Attention-deficit-hyperactivity disorder: an update.Methylphenidate and μ opioid receptor interactions: a pharmacological target for prevention of stimulant abuse.The effects of a Self-Alert Training (SAT) program in adults with ADHD.Genome-wide analysis of attention deficit hyperactivity disorder in Norway.Prevalence and incidence of attention-deficit/hyperactivity disorder in Slovenian children and adolescents: a database study from a national perspectiveWhy does the worldwide prevalence of childhood attention deficit hyperactivity disorder matter?Long-term consequences of childhood ADHD on criminal activities.A 4-Year Follow-Up Study of Attention-Deficit Hyperactivity Symptoms, Comorbidities, and Psychostimulant Use in a Brazilian Sample of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.Social and emotional difficulties in children with ADHD and the impact on school attendance and healthcare utilization.Costs and treatment patterns of incident ADHD patients - a comparative analysis before and after the initial diagnosisImpact of attention-deficit/hyperactivity disorder (ADHD) on prescription dug spending for children and adolescents: increasing relevance of health economic evidence.Service use patterns for adolescents with ADHD and comorbid conduct disorderCost effectiveness of guanfacine extended release as an adjunctive therapy to a stimulant compared with stimulant monotherapy for the treatment of attention-deficit hyperactivity disorder in children and adolescentsSustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studiesOrigins of altered reinforcement effects in ADHD.Change in the direct cost of treatment for children and adolescents with hyperkinetic disorder in Germany over a period of four years.Global issues related to the impact of untreated attention-deficit/hyperactivity disorder from childhood to young adulthood.The weighed core symptom scale and prediction of ADHD in adults - objective measures of remission and response to treatment with methylphenidate.Comparison of child self-reports and parent proxy-reports on quality of life of children with attention deficit hyperactivity disorder.The prevalence and incidence, resource use and financial costs of treating people with attention deficit/hyperactivity disorder (ADHD) in the United Kingdom (1998 to 2010).Attention Deficit/Hyperactivity Disorder symptoms and cognitive abilities in the late-life cohort of the PATH through life study.Prevalence of attention-deficit/hyperactivity disorder among children with vision impairment.Treatment costs of attention deficit hyperactivity disorder in Germany.Attention deficit hyperactivity disorder in offenders and the need for early intervention.Can transcranial electrical stimulation improve learning difficulties in atypical brain development? A future possibility for cognitive training.Efficacy and Safety of a Chewable Methylphenidate Extended-Release Tablet in Children with Attention-Deficit/Hyperactivity Disorder.Imaging genetics in adult attention-deficit/hyperactivity disorder (ADHD): a way towards pathophysiological understanding?Lisdexamfetamine: A Review in ADHD in Adults.Preschool hyperactivity increases costs into early adulthood.Further evidence for the role of pregnancy-induced hypertension and other early life influences in the development of ADHD: results from the IDEFICS study.Cardiovascular Safety of Concomitant Use of Atypical Antipsychotics and Long-Acting Stimulants in Children and Adolescents With ADHD.Attention problems in very preterm children from childhood to adulthood: the Bavarian Longitudinal Study.ADHD in children: a path to free medicines.
P2860
Q21260319-A74B9C4F-22A4-4E1D-9574-32F5B21CF4D1Q30251626-5FBC574B-67C8-4EA6-9893-E056231D56F2Q33617689-025AB92B-C764-4EB0-95A7-83F9A83F5E59Q34041439-2ABBE228-ABE9-4194-877B-C5644354FCD6Q34162864-71C8692E-4E7B-4CA3-9BD7-D0420453869FQ34588668-ABED8ADC-99BA-41ED-AF2B-FE04E5093847Q34722355-91860A9F-49CD-4DC5-98C5-BE2371BA2BE1Q34983475-F4964728-3A1B-4264-BD05-08C024C731C2Q35016913-5BF42AB5-BABE-41AC-A57E-1EAEDF952510Q35067022-66A57F22-31AC-4041-A95D-FF7713D1B574Q35393713-F9C250ED-2158-4598-A8FA-61A6BC81A9E3Q35539548-631113D7-CE19-4FE1-80FB-E881176C4BF2Q36015271-5DF5AE8D-831C-4CE5-8F55-4AAFEF648E03Q36098336-C4AEB9C5-1F74-4138-8A82-F34FEBAE48F4Q36114644-0FFDA0C1-111F-45B6-AA3C-CAD61E916138Q36373583-FDBC4FD7-BD5D-4229-A2F4-C0A5A68B2122Q36391457-A4F8D359-13E9-45C6-AF7B-729F12E3D802Q36409734-7D048EE2-D3CA-461F-84AB-2B8537F421EAQ36500967-52BE532C-EC04-49BA-8A3A-BCE2605336A2Q36623089-ECC2543A-950C-4BD4-AF7C-7D6D797B04BEQ36740926-E1951847-31A7-4E2B-B13F-AF8EBF55CB14Q37114200-231F407F-7BFE-4E62-90D4-8D642AD9309AQ37126206-22C9BAF1-57A6-45A7-AC66-3D425C3F9979Q37282163-D1B656DD-C141-4F92-AB4D-F5A83531442CQ37289793-4967781A-C48C-4465-9F95-390C430B3BB3Q37348253-38A47CD0-4A79-4566-94D6-4AAC8111D2C9Q37376766-8EC8273B-D436-44AC-80E0-5147FDDC2E4BQ37525346-C38E5970-C0AF-4DF5-AF98-B349DB33C2AAQ37657872-35A9EABD-A085-491F-B881-22C56FD6AE30Q38062338-2A6FAC79-E5A4-4643-A68E-0EDEFDD6E5EDQ38065857-5847D74D-7A7D-4756-8DC3-FE6FD62847EAQ38114707-79C34623-C889-49DD-864B-70EA216641FEQ38376209-E0A147CE-7C39-4C24-BBDA-63DDED338070Q38592018-E5FBCD8D-A186-4BED-A928-1ED108C6BD0EQ38799006-9940B834-604F-46E4-B5BD-30F21C4E4414Q40204671-862F3D52-29CE-44A3-B91A-9EF408A18066Q40309105-D7F7D9EC-086A-4958-B848-6C6B3E7D77FEQ40400512-D474F5C3-D85F-4EC4-8179-4CD0B0D5CD04Q40628324-9E682AD8-AF29-4F3E-878C-4770CBF5425EQ41448511-BCB80BA1-89F4-4E7A-9912-7C7B998CFE95
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
A review of the economic burden of ADHD
@ast
A review of the economic burden of ADHD
@en
A review of the economic burden of ADHD
@nl
type
label
A review of the economic burden of ADHD
@ast
A review of the economic burden of ADHD
@en
A review of the economic burden of ADHD
@nl
prefLabel
A review of the economic burden of ADHD
@ast
A review of the economic burden of ADHD
@en
A review of the economic burden of ADHD
@nl
P2093
P2860
P356
P1476
A review of the economic burden of ADHD
@en
P2093
Clark Paramore
Louis S Matza
Manishi Prasad
P2860
P2888
P356
10.1186/1478-7547-3-5
P407
P577
2005-06-09T00:00:00Z
P5875
P6179
1027322020